A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

103 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-31

Study Completion Date

2009-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle glaucoma or ocular hypertension were asked to complete a survey regarding their normal treatment. No treatment was prescribed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension

NCT00804648

Glaucoma, Open Angle Ocular Hypertension

COMPLETED PHASE4

Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension

NCT00822081

Open-Angle Glaucoma Ocular Hypertension

COMPLETED PHASE4

Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension

NCT00822055

Open-Angle Glaucoma Ocular Hypertension

COMPLETED PHASE4

Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

NCT01062971

Primary Open Angle Glaucoma Ocular Hypertension

COMPLETED PHASE2

Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)

NCT00108017

Glaucoma Ocular Hypertension

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Open-angle Glaucoma Ocular Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Timolol hemihydrate

Subjects currently prescribed timolol hemihydrate 0.5% solution.

timolol hemihydrate

Intervention Type DRUG

timolol hemihydrate 0.5% solution

Timolol maleate

Subjects currently prescribed timolol maleate in sorbate.

timolol maleate

Intervention Type DRUG

timolol maleate in sorbate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

timolol hemihydrate

timolol hemihydrate 0.5% solution

Intervention Type DRUG

timolol maleate

timolol maleate in sorbate

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* willing to comply with investigator's and protocol's instructions
* patients signature on the informed consent document
* open-angle glaucoma or ocular hypertension
* currently prescribed timolol hemihydrate (once a day (QD) or twice a day (BID))or timolol maleate in sorbate QD as monotherapy or as a part of 2-drug therapy in at least one eye

Exclusion Criteria

* inability to understand the trial procedures
* inability to give informed consent
* inability to understand, read, or write English
* best corrected visual acuity of 20/200 or worse in each eye
* current moderate to severe infectious or inflammatory condition of the eye or eyelids including
* current moderate to severe dry eye syndrome
* current chronic use of ocular corticosteroids, ocular surgery or intraocular laser surgery to either eye in the prior 3 months
* treated with 3 or more glaucoma medicines in both eye

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No